Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease, is known to increase the risk of colitis-associated cancer (CAC). CAC has been found to be unresponsive to standard chemotherapy regimens, and the current treatments do not utilize effective small-molecule...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Dingpei, Alghoul, Zahra, Sung, Junsik, Yang, Chunhua, Merlin, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534593/
https://www.ncbi.nlm.nih.gov/pubmed/37765299
http://dx.doi.org/10.3390/pharmaceutics15092331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534593/
https://www.ncbi.nlm.nih.gov/pubmed/37765299
http://dx.doi.org/10.3390/pharmaceutics15092331

Ejemplares similares